CB21 Pharma

Pharmaceutical Manufacturing • Brno, South Moravian Region, Czechia • 1-10 Employees

Company overview

Headquarters	Studentská 812, Brno, Jihomoravský 625 00, CZ
Phone number	+420739000076
Website	cb21pharma.com
NAICS	3254
Keywords	Ce Marking & Eu Mdr Compliance, Cannabinoid Medical Devices, Clinical Validation & Evidence-Based Development, Gmp/Api Manufacturing, Multi-Therapeutic Platform, Pan-European Market Access, Patent-Protected Innovation
Employees	1-10
Socials

Key Contact at CB21 Pharma

Jan Storch

Co-Founder And Ceo

CB21 Pharma Email Formats

CB21 Pharma uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@cb21pharma.com), used 83.3% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@cb21pharma.com	83.3%
{first initial}.{last name}	j.doe@cb21pharma.com	16.7%

About CB21 Pharma

CB21 Pharma leads Europe in science-backed, trusted innovation for accessible CBD healthcare. Our portfolio includes the EU’s only three CE-marked cannabinoid medical devices, setting the standard for regulatory excellence and clinical validation. Our science-backed solutions span Women’s Health, Proctology, Urology, Oral Care, and Mental Well-Being—delivering quality, efficacy, and safety to patients across 27 European markets. We combine deep expertise in EU MDR compliance, GMP-certified manufacturing, and rapid adaptation to evolving pharmacopoeia standards. Our integrated regulatory and IP strategy provides market exclusivity through 2041, offering partners a de-risked, scalable platform for transformative health solutions.

CB21 Pharma revenue & valuation

Annual revenue	$513,330
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$1,700,000
Total funding	No funding